Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Vaccines 29

Vaccines Pharmacy Technician Immunization Immunity 29

Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 29

Pharmacy Times

JUNE 27, 2025

Treatment-related adverse events (AEs) included nausea (77.8% vs 10.8%, respectively), and major bleeding events (2.4% 5 Primary end points included safety, with secondary end points of overall response rate (ORR), progression-free survival (PFS), and duration of response. ORRs were 94.4% in the TN cohort (95% CI, 72.7%-99.9%)

Pharmacy Technician 22

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 22

Pharmacy Times

JUNE 24, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 49

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 49

Pharmacy Times

JUNE 19, 2025

Nacher : I think, as I said, rusfertide being a first-in-class hepcidin mimetic is huge—especially for patients with [PV]—to hopefully reduce the phlebotomy burden and prevent some of the sequelae of the disease, including cardiovascular and thrombotic events.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes 26

Pharmacy Times

JUNE 18, 2025

2 More recent changes in many states include the ability to prescribe oral contraceptives and plan outreach events to monitor blood pressure or cholesterol; the latter, when coupled with referral to appropriate medical services, is a valuable intervention. 2 The pharmacy profession needs to improve in 2 areas.

Pharmacy Technician 26

Pharmacy Technician Immunization Immunity Diabetes 26

Pharmacy Times

JULY 12, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies 26

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Pharmacy Technician 20

Pharmacy Technician Immunization Immunity Diabetes 20

Pharmacy Times

JUNE 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management 26

PharmaTech

JUNE 10, 2025

Related Content Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia Patrick Lavery June 9th 2025 Article The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

Pharmacy Times

JUNE 23, 2025

By meticulously reviewing medication regimens, reconciling discrepancies, and providing comprehensive education to patients and caregivers, they significantly reduce the likelihood of medication errors and adverse drug events during these vulnerable periods.

Pharmacy Technician 26

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 20

Pharmacy Technician Medication Therapy Management (MTM) Vaccines Compounding Pharmacies 20

Pharmacy Times

JULY 8, 2025

The regimen maintained stem cell collection feasibility with no new safety concerns, despite some adverse events like neutropenia and infections. Five patients died during this time, with causes including disease progression (n = 1), cardiac events (n = 2), and other unrelated causes (n = 2).

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Immunization Immunity 29

Pharmacy Times

JUNE 20, 2025

Adverse events were common but comparable between dupilumab and placebo, with no deaths in the dupilumab group. 3 Overall rates of adverse events (AEs) were 96% (n = 51) in the dupilumab arm and 96% (n = 51) in the placebo.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 33

BioPharma Dive

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief Actithera draws new investors to radiopharma drug pitch The four-year-old biotech raised about $75 million in a Series A round that involved nine venture capital firms.

Drug Pricing 60

Drug Pricing Compounding Immunization Immunity 60

Pharmacy Times

JUNE 30, 2025

REMS ensured drug safety by requiring certified hospitals to have tocilizumab for severe adverse events management. 2 Critically, a REMS designation does not automatically translate to universal mitigation of adverse events associated with a medication. Only some medications—including CAR T therapies—carry REMS designations.

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Immunization Immunity 40

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What role do you see pharmacists playing in the discussions and advancements presented at the event? There are going to be a lot of key takeaways that will be important for the pharmacist to know. Isaacs: It's great if pharmacists can be there, but even if not, there's a virtual option as well.

Diabetes 32

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 32

Express Pharma

JUNE 20, 2025

Establish revalidation triggers based on risk events such as new equipment, layout changes, or shifts in personnel competency. The case led to criminal convictions and lasting changes in compounding pharmacy regulations. Define clear lifecycle plans for process validation, visual inspection qualification, and CCI.

Documentation 66

Documentation Compounding Compounding Pharmacies Pharmaceutical Manufacturing 66

Pharmacy Times

JUNE 17, 2025

Among the 37 practices that reported waste, 768 events were reported, leading to a total drug waste of $11,275,642.16. These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. compared with $546,082.45 for the external mail-order pharmacies. Of that, $8,935,612.15

Mail-Order Pharmacies 29

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient 29

Pharmacy Times

JUNE 9, 2025

The primary end point was mean change in home systolic BP (SBP) from baseline to week 12, and the primary safety outcome was treatment discontinuation due to an adverse event (AE) from baseline to week 12, with secondary end points including differences in clinic and home blood pressure levels and control rates.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 33

Pharmacy Times

JUNE 26, 2025

Participants experienced no severe hypoglycemic events, and glycated hemoglobin levels remained below 7%. Most adverse events were mild or moderate, with no serious events linked to zimislecel. The FORWARD trial's phase 3 aims to evaluate zimislecel's safety and efficacy over five years.

Diabetes 37

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 37

Pharmacy Times

JULY 12, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Dosage Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JULY 2, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Inpatient Compounding Pharmacies Hospitals 26

Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Immunization Immunity 26

Pharmacy Times

JUNE 23, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmacy Times

JUNE 27, 2025

A comprehensive review of 90 studies involving more than 14,000 patients demonstrated no increase in adverse events, immunogenicity, or loss of clinical effectiveness following a switch. Scientific evidence does not support the belief that switching from a reference biologic to a biosimilar compromises safety or efficacy.

Biosimilars 20

Biosimilars Pharmacy Technician Diabetes Compounding Pharmacies 20

Pharmacy Times

JULY 10, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 20

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management 20

Pharmacy Times

JULY 4, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Biosimilars 34

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals 34

Pharmacy Times

JULY 2, 2025

Adverse events include infusion reactions, nephrotoxicity, and ototoxicity, with pediatric patients potentially experiencing more severe reactions. The ready-to-infuse formulation simplifies administration, reducing preparation steps and enhancing treatment efficiency in healthcare settings.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Compounding 29

Pharmacy Times

JULY 15, 2025

Cytokine release syndrome was the most common adverse event, occurring in 80% of patients, with 3% experiencing grade 3 or higher. 4 The safety profile showed cytokine release syndrome (CRS) as the most common adverse event (AE) in 80% of patients, of which 3% experienced grade 3 or higher CRS. 4 At the median follow-up of 11.6

Pharmacy Technician 29

Pharmacy Technician Immunization Immunity Compounding Pharmacies 29

Pharmacy Times

JULY 1, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents 44

HIV Treatment and Prevention Agents Pharmacy Technician Insurance Coverage and Processing Specialty Pharmacies 44

Pharmacy Times

JULY 7, 2025

3 All 100 patients also displayed a favorable safety profile with 85% mild to moderate adverse events and 4 device- or procedure-related serious adverse events, including abdominal pain, radioembolization-induced liver disease, and nausea. Additionally, all evaluable patients demonstrated a 100% local tumor control rate.

Pharmacy Technician 20

Pharmacy Technician Compounding Pharmacies Diabetes Pharmacy Management 20

Pharmacy Times

JUNE 20, 2025

Despite high adverse event rates, dupilumab had no treatment-related deaths, unlike the placebo group, which had two. 3 Overall rates of adverse events (AEs) were 96% (n = 51) in the dupilumab arm and 96% (n = 51) in the placebo.

Pharmacy Technician 26

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JULY 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Immunization Immunity Compounding Pharmacies 26

Pharmacy Times

JUNE 22, 2025

SHOW MORE Oral semaglutide shows promising cardiovascular benefits for type 2 diabetes patients, reducing major adverse events by 14% in the SOUL trial. Secondary outcomes included major kidney disease events based on a 5-point composite, as well as major adverse limb events.

Pharmacy Technician 22

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 22

Pharmacy Times

JULY 14, 2025

Dave Randolph | Image courtesy of McKesson The highlight of this year’s event was the announcement of Dave’s Pharmacy in Alliance, Nebraska, as the winner of the Pharmacy of the Year Award, recognizing the pharmacy’s outstanding contributions to patient care and community health.

Independent Pharmacies 26

Independent Pharmacies Pharmacy Technician Compounding Pharmacies Hospitals 26